Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma

Annals of Hematology
Wei Ping LiuJun Zhu

Abstract

Interstitial pneumonia (IP) is a lethal complication in lymphoma patients undergoing chemotherapy. A total of 2212 consecutive patients diagnosed with lymphoma between 2009 and 2014 were enrolled in the present study. IP was defined as diffuse pulmonary interstitial infiltrate found on computed tomography scans. IP was observed in 106 patients. Of these, 23 patients were excluded from the study. Finally, 83 patients with IP were included in this study. The incidence of IP was 3.9% (7/287) in Hodgkin lymphoma and 2.4% (76/1925) in non-Hodgkin lymphoma (P = 0.210). The median number of chemotherapy cycles before IP was 3. The median time from the cessation of chemotherapy to IP was 17 days. Eighty-two (98.8%) patients recovered after the treatment with glucocorticoids. Sixty-six (79.5%) patients had a delay in chemotherapy, and 14 (16.9%) patients had premature termination of chemotherapy. Sixty-nine patients were re-treated with chemotherapy after remission from IP, of which 22 (31.9%) experienced IP recurrence. The incidence of IP recurrence was significantly higher in patients re-treated with a similar regimen than in those re-treated with an alternative regimen (65.4 vs. 11.6%, P < 0.001). In a multivariate Cox regression ana...Continue Reading

References

Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William G MartinStephen M Ansell
Jan 16, 2008·Radiology·David M HansellJacques Remy
Apr 15, 2008·International Journal of Hematology·Daisuke EnnishiKiyohiko Hatake
Nov 19, 2013·Respiratory Investigation·Keishi KuboUNKNOWN Japanese Respiratory Society Committee for formulation of Consensus statement for the diagnosis and treatment of drug-induce
May 30, 2014·Japanese Journal of Clinical Oncology·Motoko TachiharaYoshihiro Nishimura
Jan 8, 2015·The Annals of Pharmacotherapy·Takumi SakuradaKeisuke Ishizawa
May 21, 2015·American Society of Clinical Oncology Educational Book·Michael A Postow
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
Dec 25, 2015·Blood·Anthony R MatoStephen J Schuster
Feb 15, 2016·Cancer Treatment Reviews·Lavinia SpainJames Larkin
Feb 27, 2016·The European Respiratory Journal·Eglantine HaustraeteAnne Bergeron
Apr 14, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yoon-Kyoung LeeJoongbum Cho
May 14, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Masatoshi HanadaShigeru Kohno
Aug 19, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mizuki NishinoF Stephen Hodi
Apr 13, 2017·Chest·Natalya AzadehJay H Ryu
Jul 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B A G HaanenUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
bronchoalveolar
biopsy

Software Mentioned

Statistical Package for the Social Sciences ( SPSS
CTCAT

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Zhenchang SunMingzhi Zhang
[Rinshō ketsueki] The Japanese journal of clinical hematology
Motoko Yamaguchi
© 2022 Meta ULC. All rights reserved